The BBIL promoters headed by Dr Krishna Ella have bought 47.06% of the company’s optionally convertible preference shares from ICICI Venture through the promoters-controlled vaccines producer Biovet Private Ltd, two persons in the know of developments told ET.
– Stocks-Markets-Economic Times
